Aridis Pharmaceuticals In...

0.00
-0.00 (-100.00%)
At close: Feb 28, 2025, 9:52 AM
0.00
-99.00%
Pre-market: Oct 07, 2024, 09:30 AM EDT

Aridis Pharmaceuticals Balance Sheet Statement

Year FY22 FY21 FY20 FY19 FY18 FY17 FY16
Cash & Equivalents 4.88M 19.99M 8.23M 20.9M 24.24M 25.1M 22.29M
Short-Term Investments n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a 9K 960K n/a n/a
Other Long-Term Assets 905K -1.38M -1.28M -1.05M 7.37M 345K 41K
Receivables 1.24M 237K 368K 413K 2.1M n/a 67K
Inventory n/a -237K -368K -413K -4.11M n/a n/a
Other Current Assets 5.51M 6.05M 4.16M 4.53M 2.01M 244K 51K
Total Current Assets 11.63M 26.8M 15.12M 27.97M 24.24M 25.34M 22.41M
Property-Plant & Equipment 2.15M 1.36M 1.26M 1.01M 1.27M 750K 39K
Goodwill & Intangibles 17K 22K 27K 32K 38K 43K 48K
Total Long-Term Assets 3.07M 2.31M 2.27M 1.6M 7.37M 1.14M 128K
Total Assets 14.7M 26.8M 15.12M 27.97M 31.61M 26.48M 22.54M
Account Payables 2.31M 5.24M 1.89M 1.75M 2.33M 933K 678K
Deferred Revenue 20.17M 20.84M 18.75M 14.6M 22K 120K n/a
Short-Term Debt 4.84M 696K 439K n/a n/a n/a n/a
Other Current Liabilities 9.58M 6.57M 1.37M 2.97M 2.94M 2.12M 1.72M
Total Current Liabilities 36.9M 33.35M 22.44M 19.33M 5.3M 3.17M 2.4M
Long-Term Debt 1.29M 5.28M 276K n/a n/a n/a n/a
Other Long-Term Liabilities n/a 363K 228K n/a n/a 11.87M 6.37M
Total Long-Term Liabilities 2.03M 6.56M 1.36M 5M n/a 11.87M 6.37M
Total Liabilities 38.93M 40.91M 23.8M 24.33M 5.3M 15.04M 8.76M
Total Debt 6.13M 5.98M 715K n/a n/a n/a n/a
Common Stock 3K 2K 1K 1K 1K n/a n/a
Retained Earnings -195.67M -165.29M -123.1M -100.77M -71.09M -47.63M -20.18M
Comprehensive Income 5.05M n/a n/a n/a -491K -215K -158K
Shareholders Equity -24.23M -14.11M -8.68M 3.64M 26.31M 11.44M 13.78M
Total Investments n/a n/a n/a 9K 960K n/a n/a